Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Saylor

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Michigan Hospitals|December 10, 1991
Are you violating antitrust laws?L J Saylor
Nature Reviews. Clinical Oncology|May 11, 2011
Targeted therapies: denosumab--a new option for solid tumors metastatic to bonePhilip J Saylor
The Oncologist|June 27, 2021
Informed Consent 2021: The "Terms and Conditions" of the Research WorldPhilip J Saylor
Asian Journal of Andrology|January 18, 2014
Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancerPhilip J Saylor
Health Law Vigil|December 26, 1986
Federal court grants summary judgment in Huron Valley caseL J Saylor
The Journal of Urology|July 21, 2010
Re: Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy. Editorial commentPhilip J Saylor
Nature Reviews. Clinical Oncology|February 6, 2013
Prostate cancer: The androgen receptor remains front and centrePhilip J Saylor
Brain Structure & Function|October 13, 2010
An intrastriatal brain-derived neurotrophic factor infusion restores striatal gene expression in Bdnf heterozygous miceAlicia J Saylor, Jacqueline F McGinty
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancerPhilip J Saylor, Matthew R Smith
The Journal of Urology|December 14, 2012
Metabolic complications of androgen deprivation therapy for prostate cancerPhilip J Saylor, Matthew R Smith
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Michigan Hospitals|December 10, 1991
Are you violating antitrust laws?L J Saylor
Nature Reviews. Clinical Oncology|May 11, 2011
Targeted therapies: denosumab--a new option for solid tumors metastatic to bonePhilip J Saylor
The Oncologist|June 27, 2021
Informed Consent 2021: The "Terms and Conditions" of the Research WorldPhilip J Saylor
Asian Journal of Andrology|January 18, 2014
Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancerPhilip J Saylor
Health Law Vigil|December 26, 1986
Federal court grants summary judgment in Huron Valley caseL J Saylor
The Journal of Urology|July 21, 2010
Re: Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy. Editorial commentPhilip J Saylor
Nature Reviews. Clinical Oncology|February 6, 2013
Prostate cancer: The androgen receptor remains front and centrePhilip J Saylor
Brain Structure & Function|October 13, 2010
An intrastriatal brain-derived neurotrophic factor infusion restores striatal gene expression in Bdnf heterozygous miceAlicia J Saylor, Jacqueline F McGinty
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancerPhilip J Saylor, Matthew R Smith
The Journal of Urology|December 14, 2012
Metabolic complications of androgen deprivation therapy for prostate cancerPhilip J Saylor, Matthew R Smith
Pageof 9